What You Should Know:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing…
Continue Reading
What You Should Know:
– Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
– Leveraging the power of Paige’s Foundation…
Continue Reading
What You Should Know:
– CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital…
Continue Reading
What You Should Know: – Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute…
Continue Reading
What You Should Know:
– Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP…
Continue Reading
By Hannah Nelson
March 04, 2024 – Maryland-based Frederick Health has completed a MEDITECH EHR integration to elevate its precision medicine program.
The integration of Expanse Genomics within the health systems’ MEDITECH Expanse EHR allows Frederick Health…
New adjunct specialty facilities in India’s leading health institutions are advancing precision medicine in the country through AI. The Apollo Cancer Centre (ACC) in Bengaluru has recently opened what could be the country’s first Precision…
Continue Reading
The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise…
Continue Reading
What You Should Know:
– Aranscia, a global provider of diagnostics software, services, and testing solutions, has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction.
– YouScript…
Continue Reading
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
